Abstract
This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.
Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate
Current Drug Targets
Title: A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials
Volume: 11 Issue: 5
Author(s): David J. Hunter, Elena Losina, Ali Guermazi, Deb Burstein, Marissa N. Lassere and Virginia Kraus
Affiliation:
Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate
Abstract: This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.
Export Options
About this article
Cite this article as:
J. Hunter David, Losina Elena, Guermazi Ali, Burstein Deb, N. Lassere Marissa and Kraus Virginia, A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials, Current Drug Targets 2010; 11 (5) . https://dx.doi.org/10.2174/138945010791011947
DOI https://dx.doi.org/10.2174/138945010791011947 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy
Current Alzheimer Research Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
Current Pharmaceutical Design Evaluation of Blood Oxidant/Antioxidant Changes and Testicular Toxicity after Subacute Exposure to Cadmium in Albino Rats: Therapeutic Effect of <i>Nigella sativa</i> Seed Extracts
Combinatorial Chemistry & High Throughput Screening Protein-Energy Malnutrition Alters Thermoregulatory Homeostasis and the Response to Brain Ischemia
Current Neurovascular Research Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety Anticholinergic Burden Among Hospitalised Older Adults with Psychiatric Illnesses- A Retrospective Study
Current Drug Safety Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors
Current Medicinal Chemistry Role of Nut Consumption in the Management of Cognitive Decline - A Mini-Review
Current Alzheimer Research Genetic Determinants of Cerebral Arterial Adaptation to Flow-loading
Current Neurovascular Research ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry Cross-Interplay between Osmolytes and mTOR in Alzheimer's Disease Pathogenesis
Current Pharmaceutical Design Editors Perspective (Throwing Caution to the Wnts)
Current Neurovascular Research Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Acid-Sensing Ion Channels: A Novel Therapeutic Target for Pain and Anxiety
Current Pharmaceutical Design How Should We Deal with Missing Data in Clinical Trials Involving Alzheimers Disease Patients?
Current Alzheimer Research Opioid Receptors and Their Ligands in the Musculoskeletal System and Relevance for Pain Control
Current Pharmaceutical Design Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review
Current Drug Targets Developmental Synaptogenesis and General Anesthesia: A Kiss of Death?
Current Pharmaceutical Design From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery
Current Topics in Medicinal Chemistry